Sandra Sitar
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Viral Infections and Outbreaks Research, Viral Infections and Vectors, HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies
Most-Cited Works
- → Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine(2013)772 cited
- → A proof of concept for structure-based vaccine design targeting RSV in humans(2019)327 cited
- → Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials(2017)300 cited
- → Chimpanzee Adenovirus Vector Ebola Vaccine(2014)281 cited
- → Accelerated COVID-19 vaccine development: milestones, lessons, and prospects(2021)263 cited
- → Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults(2015)251 cited
- → Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults(2018)251 cited
- → Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial(2014)248 cited
- → Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial(2022)157 cited
- → Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect(2013)131 cited